Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome.
Yavuz
Sule
S
Department of Rheumatology, Marmara University Medical School, Istanbul, Turkey. suleyavuz@gmail.com
Asfuroğlu
Esra
E
Bicakcigil
Muge
M
Toker
Ebru
E
D000328:Adult; D000368:Aged; D053264:B-Cell Activating Factor / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use*; D007638:Keratoconjunctivitis Sicca / Q000188:drug therapy*; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D012859:Sjogren's Syndrome / Q000188:drug therapy* / Q000378:metabolism; D013666:Tears / Q000378:metabolism; D016896:Treatment Outcome; D014987:Xerostomia / Q000188:drug therapy*; D055815:Young Adult
D053264:B-Cell Activating Factor; D015415:Biomarkers; D009883:Ophthalmic Solutions; D006886:Hydroxychloroquine